Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/33056
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRossello, Xavier-
dc.contributor.authorDorresteijn, Jannick A. N.-
dc.contributor.authorJANSSEN, Arne-
dc.contributor.authorLambrinou, Ekaterini-
dc.contributor.authorSCHERRENBERG, Martijn-
dc.contributor.authorBonnefoy-Cudraz, Eric-
dc.contributor.authorCobain, Mark-
dc.contributor.authorPiepoli, Massimo F.-
dc.contributor.authorVisseren, Frank L. J.-
dc.contributor.authorDENDALE, Paul-
dc.date.accessioned2021-01-06T13:12:56Z-
dc.date.available2021-01-06T13:12:56Z-
dc.date.issued2020-
dc.date.submitted2020-12-22T13:33:04Z-
dc.identifier.citationEUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 9 (5) , p. 522 -532-
dc.identifier.urihttp://hdl.handle.net/1942/33056-
dc.description.abstractRisk assessment and risk prediction have become essential in the prevention of cardiovascular disease. Even though risk prediction tools are recommended in the European guidelines, they are not adequately implemented in clinical practice. Risk prediction tools are meant to estimate prognosis in an unbiased and reliable way and to provide objective information on outcome probabilities. They support informed treatment decisions about the initiation or adjustment of preventive medication. Risk prediction tools facilitate risk communication to the patient and their family, and this may increase commitment and motivation to improve their health. Over the years many risk algorithms have been developed to predict 10-year cardiovascular mortality or lifetime risk in different populations, such as in healthy individuals, patients with established cardiovascular disease and patients with diabetes mellitus. Each risk algorithm has its own limitations, so different algorithms should be used in different patient populations. Risk algorithms are made available for use in clinical practice by means of - usually interactive and online available - tools. To help the clinician to choose the right tool for the right patient, a summary of available tools is provided. When choosing a tool, physicians should consider medical history, geographical region, clinical guidelines and additional risk measures among other things. Currently, the website is the only risk prediction tool providing prediction algorithms for all patient categories, and its implementation in clinical practice is suggested/advised by the European Association of Preventive Cardiology.-
dc.description.sponsorshipThe author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this paper was produced within the framework of the ESC Prevention of Cardiovascular Disease Programme which is led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). The ESC Prevention of Cardiovascular Disease Programme is supported by unrestricted educational grants. The authors received no financial support for the research, authorship, and/or publication of this article.-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.rightsThe European Society of Cardiology 2019.-
dc.subject.otherRisk prediction-
dc.subject.otherRisk prediction-
dc.subject.otherrisk assessment-
dc.subject.otherrisk assessment-
dc.subject.othercardiovascular disease-
dc.subject.othercardiovascular disease-
dc.subject.otherprevention-
dc.subject.otherprevention-
dc.subject.otherpatient Keywords Risk prediction-
dc.subject.otherpatient-
dc.subject.otherpatient-
dc.titleRisk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)-
dc.typeJournal Contribution-
dc.identifier.epage532-
dc.identifier.issue5-
dc.identifier.spage522-
dc.identifier.volume9-
local.format.pages11-
local.bibliographicCitation.jcatA1-
dc.description.notesRossello, X (corresponding author), Ctr Nacl Invest Cardiovasc CNIC Carlos III, Melchor Fernandez Almagro 3, Madrid 28029, Spain.-
dc.description.notesfjrossello@cnic.es-
dc.description.otherRossello, X (corresponding author), Ctr Nacl Invest Cardiovasc CNIC Carlos III, Melchor Fernandez Almagro 3, Madrid 28029, Spain. fjrossello@cnic.es-
local.publisher.place1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1177/2048872619858285-
dc.identifier.pmid31303009-
dc.identifier.isiWOS:000589950100021-
dc.contributor.orcidRossello, Xavier/0000-0001-6783-8463-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Rossello, Xavier] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain.-
local.description.affiliation[Rossello, Xavier; Visseren, Frank L. J.] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.-
local.description.affiliation[Dorresteijn, Jannick A. N.] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands.-
local.description.affiliation[Janssen, Arne; Lambrinou, Ekaterini] Jessa Hosp, Heartctr Hasselt, Clin Res Dept Cardiol, Hasselt, Belgium.-
local.description.affiliation[Lambrinou, Ekaterini] Cyprus Univ Technol, Dept Nursing, Limassol, Cyprus.-
local.description.affiliation[Scherrenberg, Martijn; Dendale, Paul] Jessa Hosp, Heartctr Hasselt, Hasselt, Belgium.-
local.description.affiliation[Scherrenberg, Martijn; Dendale, Paul] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.-
local.description.affiliation[Bonnefoy-Cudraz, Eric] Hosp Cardiol Lyon, Dept Cardiol, Lyon, France.-
local.description.affiliation[Cobain, Mark] Imperial Coll, Dept Cardiovasc Med, London, England.-
local.description.affiliation[Piepoli, Massimo F.] G Saliceto Hosp, Heart Failure Unit, Cardiol, Piacenza, Italy.-
local.description.affiliation[Piepoli, Massimo F.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA.-
item.fullcitationRossello, Xavier; Dorresteijn, Jannick A. N.; JANSSEN, Arne; Lambrinou, Ekaterini; SCHERRENBERG, Martijn; Bonnefoy-Cudraz, Eric; Cobain, Mark; Piepoli, Massimo F.; Visseren, Frank L. J. & DENDALE, Paul (2020) Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). In: EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 9 (5) , p. 522 -532.-
item.validationecoom 2021-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
item.contributorRossello, Xavier-
item.contributorDorresteijn, Jannick A. N.-
item.contributorJANSSEN, Arne-
item.contributorLambrinou, Ekaterini-
item.contributorSCHERRENBERG, Martijn-
item.contributorBonnefoy-Cudraz, Eric-
item.contributorCobain, Mark-
item.contributorPiepoli, Massimo F.-
item.contributorVisseren, Frank L. J.-
item.contributorDENDALE, Paul-
crisitem.journal.issn2048-8726-
crisitem.journal.eissn2048-8734-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
2048872619858285.pdfPublished version1.02 MBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

22
checked on May 16, 2024

Page view(s)

26
checked on Jun 21, 2022

Download(s)

6
checked on Jun 21, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.